Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

News Daily News

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Yael L. Maxwell

September 04, 2025

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Todd Neale

April 11, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Daily News

Abbott to Stop Making Trifecta Surgical Aortic Valves

Michael O'Riordan

July 31, 2023

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Todd Neale

February 27, 2023

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Todd Neale

December 28, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Daily News

NOTION at 8 Years: TAVI Still Comparable to Surgery

Yael L. Maxwell

July 08, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Yael L. Maxwell

March 02, 2021

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

Advertisement

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Abbott to Stop Making Trifecta Surgical Aortic Valves

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

NOTION at 8 Years: TAVI Still Comparable to Surgery

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Which TAVR Device Is Best? Review Tackles Optimal Selection

July 2020 News Roundup

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content